SMALL CELL LUNG CARCINOMA

This study tested an immunotherapy drug called pembrolizumab in people with many different types of advanced solid tumors that had stopped responding to standard treatments. The main goal was to see if the drug could shrink tumors and to identify biological markers that might pre…

This study is observing how well a drug called durvalumab works for people with advanced small cell lung cancer when used alongside standard chemotherapy in real-world medical settings. It follows 254 patients in France who are already receiving this approved treatment combinatio…

This is an early-stage safety study testing a new drug called tarlatamab in people with advanced small cell lung cancer that has returned or stopped responding to standard chemotherapy. The main goals are to find a safe dose, check for side effects, and see how the drug behaves i…

This study is testing whether adding a new drug called tiragolumab to a standard treatment regimen can better control advanced small cell lung cancer. It involved 123 patients in China who had not yet received any treatment for their extensive-stage disease. The goal is to see if…

This study is testing a three-drug combination for adults with advanced small cell or non-small cell lung cancer whose initial treatment is no longer working. The first part of the study aims to find the safest and most effective dose. The second part will see how well this combi…